Site-Specific Factor 22

Multigene Signature Method


**Note 1:** Multigene signatures or classifiers are assays of a panel of genes from a tumor specimen, intended to provide a quantitative assessment of the likelihood of response to chemotherapy and to evaluate prognosis or distant recurrence. * Oncotype DX and MammaPrint (also called MammoPrint) are two commercially available genomic tests **Note 2:** Code the type of test performed. The same test should be used to record information in **Site-Specific Factor 22, Multigene Signature Method** and **Site-Specific Factor 23, Multigene Signature Results**. **Note 3:** This information may not be available at diagnosis and may require follow-up with the physician.




NAACCR #2876


Code Description
010 Oncotype DX
020 MammaPrint (MammoPrint)
030 Other
040 Test performed, type of test unknown
988 Not applicable: Information not collected for this case
998 Test not done (test not ordered and not performed)
999 Unknown or no information
Not documented in patient record